Skip to main content
Premium Trial:

Request an Annual Quote

Luminex Q2 Revenues Rise, Losses Narrow

NEW YORK, July 23 - Luminex today reported increased net revenues for the second quarter, and significantly narrowed net losses.


The Austin, Texas company, which makes the xMap bead assay system for genomics and proteomics research, and other applications, reported revenues of $5.6 million for the quarter, compared to $3.2 million for the second quarter of 2002.


The company's R&D expenses were down sharply to $.9 million, from $2.1 million for the year-ago period.

Net losses for the quarter came to $1.9 million, compared to $6.2 million for the same period last year.


As of June 30, Luminex had $38.7 million in cash and cash equivalents.

The Scan

Unwrapping Mummies' Faces

LiveScience reports that Parabon NanoLabs researchers have reconstructed how three Egyptian mummies may have looked.

Study on Hold

The Spectrum 10K study has been put on hold due to a backlash, leading the researchers to conduct consultations with the autism community, Nature News reports.

Others Out There Already

Reuters reports that Sanofi is no longer developing an mRNA-based vaccine for SARS-CoV-2.

PNAS Papers on GWAS False Discovery, PRAMEF2 Role in Tumorigenesis, RNA Virus Reverse Genetics

In PNAS this week: strategy to account for GWAS false-discovery rates, role of PRAMEF2 in cancer development, and more.